Effect of weekly or daily dosing regimen of Gefitinib in mouse models of lung cancer
Qi Zhang(Jiangnan University), Ming You(Houston Methodist), Jiaqi Hu(Sun Yat-sen University), Éva Szabó(National Cancer Institute), Mark Steven Miller(National Cancer Institute), Ruichao Li(Ministry of Education), Donghai Xiong(Medical College of Wisconsin), Xu Chen(Huazhong University of Science and Technology), Jing Pan(Houston Methodist), Sang Beom Lee(Medical College of Wisconsin), Yian Wang(Hunan Normal University), Ronald A. Lubet(National Cancer Institute)
Cited by 31
Related Papers
TSC2 Integrates Wnt and Energy Signals via a Coordinated Phosphorylation by AMPK and GSK3 to Regulate Cell Growth
|Cell|2006|1.4k
Neoantigen vaccine: an emerging tumor immunotherapy
|Molecular Cancer|2019|718
A gene expression signature of TREM2hi macrophages and γδ T cells predicts immunotherapy response
|Nature Communications|2020|246
Targeting lonidamine to mitochondria mitigates lung tumorigenesis and brain metastasis
|Nature Communications|2019|242